These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28776206)

  • 1. Healthcare-Associated Clostridium difficile Infections are Sustained by Disease from the Community.
    McLure A; Clements ACA; Kirk M; Glass K
    Bull Math Biol; 2017 Oct; 79(10):2242-2257. PubMed ID: 28776206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection: the scope of the problem.
    Dubberke E
    J Hosp Med; 2012 Mar; 7 Suppl 3():S1-4. PubMed ID: 22407993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.
    Grigoras CA; Zervou FN; Zacharioudakis IM; Siettos CI; Mylonakis E
    PLoS One; 2016; 11(6):e0156577. PubMed ID: 27258068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonality and community interventions in a mathematical model of Clostridium difficile transmission.
    McLure A; Furuya-Kanamori L; Clements ACA; Kirk M; Glass K
    J Hosp Infect; 2019 Jun; 102(2):157-164. PubMed ID: 30880267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological model for Clostridium difficile transmission in healthcare settings.
    Lanzas C; Dubberke ER; Lu Z; Reske KA; Gröhn YT
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):553-61. PubMed ID: 21558767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings.
    Maghdoori S; Moghadas SM
    BMC Infect Dis; 2017 Jun; 17(1):384. PubMed ID: 28577357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile spores: a major threat to the hospital environment.
    Barra-Carrasco J; Paredes-Sabja D
    Future Microbiol; 2014; 9(4):475-86. PubMed ID: 24810347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital roommates and development of health care-onset Clostridium difficile infection.
    Echaiz JF; Veras L; Zervos M; Dubberke E; Johnson L
    Am J Infect Control; 2014 Oct; 42(10):1109-11. PubMed ID: 25278404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers.
    McLure A; Clements ACA; Kirk M; Glass K
    Epidemiol Infect; 2019 Jan; 147():e152. PubMed ID: 31063089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.
    Durham DP; Olsen MA; Dubberke ER; Galvani AP; Townsend JP
    Emerg Infect Dis; 2016 Apr; 22(4):608-16. PubMed ID: 26982504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model.
    Yakob L; Riley TV; Paterson DL; Clements AC
    BMC Infect Dis; 2013 Aug; 13():376. PubMed ID: 23947736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.
    Miller AC; Polgreen LA; Cavanaugh JE; Polgreen PM
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):404-10. PubMed ID: 26858126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Clostridium difficile ribotypes in symptomatic patients of a German pediatric oncology center.
    Simon A; Mock M; Graf N; von Müller L
    Eur J Pediatr; 2018 Mar; 177(3):403-408. PubMed ID: 29273940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
    Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR
    J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile Infection in travelers--a neglected pathogen?
    Neuberger A; Saadi T; Shetern A; Schwartz E
    J Travel Med; 2013; 20(1):37-43. PubMed ID: 23279229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.